Mehdi Jorfi
mehdijorfi.bsky.social
Mehdi Jorfi
@mehdijorfi.bsky.social
Assistant Professor at Harvard Medical School studying neuroimmune interactions in Alzheimer’s disease.
Reposted by Mehdi Jorfi
Immune dysfunction in Alzheimer disease — a Review by Oleg Butovsky, Neta Rosenzweig, Kilian L. Kleemann, Mehdi Jorfi, Vijay K. Kuchroo, Rudolph E. Tanzi & Howard L. Weiner

#neuroscience #neuroskyence

www.nature.com/articles/s41...
Immune dysfunction in Alzheimer disease - Nature Reviews Neuroscience
The importance of peripheral immunity in Alzheimer disease has gained much traction in recent years, mainly due to multiple genome-wide association studies identifying risk loci associated with genes ...
www.nature.com
December 1, 2025 at 9:47 AM
Reposted by Mehdi Jorfi
TET2-mutant myeloid cells mitigate Alzheimer’s disease progression via CNS infiltration and enhanced phagocytosis in mice @cp-cellstemcell.bsky.social www.cell.com/cell-stem-ce...
TET2-mutant myeloid cells mitigate Alzheimer’s disease progression via CNS infiltration and enhanced phagocytosis in mice
Matatall et al. uncover a mutation-specific association between clonal hematopoiesis (CH) and Alzheimer’s disease (AD) in mice and humans. TET2-mutant CH conferred lower odds of AD in humans and reduc...
www.cell.com
July 2, 2025 at 3:06 PM
Reposted by Mehdi Jorfi
Our perspective in @natrevimmunol.nature.com on new concepts in neuroimmune interactions that have challenged the old dogma that immune privilege is a result of the isolation of the nervous and immune systems.

@jonykipnis.bsky.social
www.nature.com/articles/s41...
Redefining CNS immune privilege - Nature Reviews Immunology
In this Perspective, Smyth and Kipnis reappraise the concept of immune privilege in the central nervous system. Although immune privilege was originally thought to involve isolation of the central ner...
www.nature.com
May 2, 2025 at 8:05 PM
Reposted by Mehdi Jorfi
Congratulations to
Dr. Jean Paul Chadarevian and the entire @blurtonjoneslab.bsky.social team for this beautiful piece of work: Harnessing human iPSC-microglia for CNS-wide delivery of disease modifying proteins." 👍👍👍
www.sciencedirect.com/science/arti...
Harnessing human iPSC-microglia for CNS-wide delivery of disease-modifying proteins
Widespread delivery of therapeutic proteins to the brain remains challenging. To determine whether human induced pluripotent stem cell (iPSC)-microgli…
www.sciencedirect.com
April 14, 2025 at 6:54 PM
Reposted by Mehdi Jorfi
With Butovsky Lab, we show that silencing TIM-3 in brain-resident immune cells prevents neurodegeneration in a mouse model of #Alzheimer’s disease. Deletion of TIM-3 in microglia enhance phagocytic clearance of toxic amyloid beta. #Immunosky🧪 www.nature.com/articles/s41...
Immune checkpoint TIM-3 regulates microglia and Alzheimer’s disease - Nature
The immune-checkpoint molecule TIM-3 regulates microglial homeostasis, and its microglial-specific deletion reduced cognitive impairment in a mouse model of Alzheimer’s disease.
www.nature.com
April 9, 2025 at 3:29 PM
Reposted by Mehdi Jorfi
Harnessing microglia-based cell therapies for the treatment of neurodegenerative diseases www.sciencedirect.com/science/arti...
March 25, 2025 at 5:40 PM
Reposted by Mehdi Jorfi
Exciting work from the Albert lab on unique signatures of human basal radial glia. And look at those beautiful organoids with their basal progenitors! 🤩
March 14, 2025 at 8:51 AM
Today marks the 1st anniversary of the Jorfi lab! This past year has been full of challenges, growth, and exciting discoveries. I’m so proud of everything our team has accomplished and grateful to work with such an amazing group. Looking forward to more milestones ahead!
January 8, 2025 at 9:59 PM
I'm thrilled to see our paper featured on the cover of
Trends in Immunology! We discuss how peripheral immune cells contribute to Alzheimer’s disease and highlight new approaches to studying neuroimmune interactions.
paper: dlvr.it/TG8M2S
#neuroimmunology #neuroimmune #Alzheimer
December 11, 2024 at 8:07 PM